SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002200
Filing Date
2020-04-09
Accepted
2020-04-09 08:02:14
Documents
5
Period of Report
2020-05-21
Effectiveness Date
2020-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241294zdef14a.htm DEF 14A 383543
2 G337105.JPG g337105.jpg GRAPHIC 24145
3 G537408.JPG g537408.jpg GRAPHIC 2386
4 G21513BEI001.GIF g21513bei001.gif GRAPHIC 133204
5 G21513BEI002.GIF g21513bei002.gif GRAPHIC 142434
  Complete submission text file 0001047469-20-002200.txt   801182
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38586 | Film No.: 20783175
SIC: 2836 Biological Products, (No Diagnostic Substances)